DuoCor 2 heart pump for severe biventricular heart failure
This trial tests a new heart pump device (DuoCor 2) that supports both sides of the heart for people with severe heart failure that has not improved with other treatments. The goal is to see if the device is safe and helps improve heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have very advanced heart failure (INTERMACS class 1 or 2) and your heart is not pumping well enough on its own.
- You need medications to keep your heart beating (inotropes) or your heart pumps very poorly.
- You have symptoms of right-side heart failure like swollen legs or a bulging neck vein.
- You are not pregnant and are willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new mechanical heart pump designed to support both sides of the heart. You may be eligible if you have advanced, severe heart failure that is not getting better with other treatments.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial is studying a non-surgical (conservative) treatment approach for people being considered for a left ventricular assist device (LVAD). It may help some patients who are too sick or unable to tolerate standard heart failure medicines, but it will only match people with specific heart function and health-test results.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This trial tests a heart pump (Corheart 6) for people with severe heart failure who are not getting better with other treatments. It may help if you need a heart assist device.
Hear when a new Advanced Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.